These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 201574)

  • 21. Epstein-Barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas.
    Desgranges C; de-Thé G
    Int J Cancer; 1979 Nov; 24(5):555-9. PubMed ID: 231014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
    Gurtsevich VE; Ruíz García R; Cuevas J; Le Riverand Morales E; Ascue M
    Vopr Virusol; 1979; (4):392-9. PubMed ID: 225887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of EBV serology in American patients with nasopharyngeal carcinoma.
    Pearson GR; Coates HL; Neel HB; Levine P; Ablashi D; Easton J
    IARC Sci Publ (1971); 1978; (20):439-48. PubMed ID: 215526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
    Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunological measurements of 'free' secretory piece and its relationship to local IgA production.
    Stockley RA; Burnett D; Afford SC
    Clin Exp Immunol; 1981 Jul; 45(1):124-30. PubMed ID: 7307344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
    Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.
    Luo YL; Ou GP; Chi PD; Liang YN; Liu YH; Huang MY
    Ai Zheng; 2009 Jan; 28(1):76-8. PubMed ID: 19448423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The usefulness of routine screening for salivary secretory component.
    Epstein MM; Baumgarten A
    J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):356-60. PubMed ID: 1890263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH; Soo MY; Gan YY; Fones-Tan A; Sim PS; Kaur A; Chew CT
    Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL; Zheng YM; Cheng JR; Wang W; Zhang YN; Wang WH; Wu YS; Zhong WM; Li J; Mo YK
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Epstein-Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography.
    Zeng J; Gong CH; Jan MG; Fun Z; Zhang LG; Li HY
    Int J Cancer; 1983 May; 31(5):599-601. PubMed ID: 6303967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ontogeny of secretory immunity: levels of secretory IgA and natural antibodies in saliva.
    Burgio GR; Lanzavecchia A; Plebani A; Jayakar S; Ugazio AG
    Pediatr Res; 1980 Oct; 14(10):1111-4. PubMed ID: 7008011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.
    Hutajulu SH; Fachiroh J; Argy G; Indrasari SR; Indrawati LPL; Paramita DK; Jati TBR; Middeldorp JM
    PLoS One; 2017; 12(8):e0180683. PubMed ID: 28800616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunohistochemical and cytochemical analysis of lymphocytes and plasma cells in nasopharyngeal carcinoma].
    Huang PS; Shen YY
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):187-9. PubMed ID: 3017661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus.
    Uen WC; Luka J; Pearson GR
    Int J Cancer; 1988 Apr; 41(4):479-82. PubMed ID: 2833449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.